The CRISPR Technology Market is extending beyond medical research as agricultural biotechnology becomes an important area of application. The market is forecast to increase from USD 5.69 billion in 2024 to USD 30.55 billion by 2035, with a CAGR of 16.5%. Increasing attention to food security, crop resilience, and sustainable agriculture is creating new opportunities for gene-editing technologies.

CRISPR can support agricultural research focused on modifying crop characteristics and improving resilience against environmental stresses, pests, and diseases. Market Research Future identifies agricultural biotechnology as one of the emerging application areas, with its growth linked to increasing demand for improved productivity and sustainable farming practices.

The expansion of agricultural applications is occurring alongside continued growth in healthcare-related research. Gene editing remains the largest application segment, accounting for approximately 65% of the market, while pharmaceuticals represent the leading end-use category. This combination demonstrates the broad applicability of CRISPR across both human health and food-production challenges.

Technology development is also influencing agricultural adoption. CRISPR-Cas9 remains the dominant technology, while CRISPR-Cas12 is identified as the fastest-growing technology type. Improvements in specificity and editing efficiency may help researchers develop increasingly targeted solutions for agricultural and industrial applications.

The future of the market will depend on continued research, investment, and evolving regulatory frameworks. As stakeholders address questions surrounding responsible gene editing and commercialization, CRISPR technology could become an increasingly important platform for developing resilient crops and supporting sustainable agricultural production.

Uncover future growth patterns with expert-driven reports:

Microsurgery Market Size

Microsurgery Market Share

Muscle Stimulator Market Trends

Muscle Stimulator Market Growth

Muscle Stimulator Market Demand